Zurit Levine
CIK: 0001972527
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
COMPUGEN LTD
Discretionary Trading P&L
Holdings
Transaction History (20 total)
- Jul 29, 2026CGEN
COMPUGEN LTD
Award(A)Direct18K shares- - Jul 9, 2026CGEN
COMPUGEN LTD
Exercise(M)Direct1.9K shares at avg. $0.83$2K - Jul 9, 2026CGEN
COMPUGEN LTD
Sale(S)Direct1.9K shares at avg. $2.50$5K - Apr 24, 2026CGEN
COMPUGEN LTD
Sale(S)Direct2K shares at avg. $3.20$6K - Apr 24, 2026CGEN
COMPUGEN LTD
Exercise(M)Direct2K shares at avg. $1.15$2K - Apr 14, 2026CGEN
COMPUGEN LTD
Exercise(M)Direct2K shares at avg. $1.15$2K - Apr 14, 2026CGEN
COMPUGEN LTD
Sale(S)Direct2K shares at avg. $2.80$6K - Apr 10, 2026CGEN
COMPUGEN LTD
Exercise(M)Direct1.1K shares at avg. $0.83$932.85 - Apr 10, 2026CGEN
COMPUGEN LTD
Exercise(M)Direct2K shares at avg. $1.15$2K - Apr 10, 2026CGEN
COMPUGEN LTD
Sale(S)Direct3.1K shares at avg. $2.56$8K - Apr 8, 2026CGEN
COMPUGEN LTD
Exercise(M)Direct4.4K shares at avg. $0.83$4K - Apr 8, 2026CGEN
COMPUGEN LTD
Exercise(M)Direct1K shares at avg. $1.15$1K - Apr 8, 2026CGEN
COMPUGEN LTD
Sale(S)Direct5.4K shares at avg. $2.42$13K - Apr 7, 2026CGEN
COMPUGEN LTD
Exercise(M)Direct2.5K shares at avg. $0.83$2K - Apr 7, 2026CGEN
COMPUGEN LTD
Sale(S)Direct2.5K shares at avg. $2.30$6K - Apr 1, 2026CGEN
COMPUGEN LTD
Exercise(M)Direct2.5K shares at avg. $0.83$2K - Apr 1, 2026CGEN
COMPUGEN LTD
Exercise(M)Direct1K shares at avg. $1.15$1K - Apr 1, 2026CGEN
COMPUGEN LTD
Sale(S)Direct3.5K shares at avg. $2.20$8K - Mar 26, 2026CGEN
COMPUGEN LTD
Exercise(M)Direct11.9K shares at avg. $0.83$10K - Mar 26, 2026CGEN
COMPUGEN LTD
Sale(S)Direct11.9K shares at avg. $2.04$24K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 29, 2026 | CGEN COMPUGEN LTD | Award(A) | 18,000 | - | $0 | Direct |
| Jul 9, 2026 | CGEN COMPUGEN LTD | Exercise(M) | 1,875 | $0.83 | $1,555 | Direct |
| Jul 9, 2026 | CGEN COMPUGEN LTD | Sale(S) | 1,875 | $2.50 | $4,688 | Direct |
| Apr 24, 2026 | CGEN COMPUGEN LTD | Sale(S) | 2,000 | $3.20 | $6,400 | Direct |
| Apr 24, 2026 | CGEN COMPUGEN LTD | Exercise(M) | 2,000 | $1.15 | $2,300 | Direct |
| Apr 14, 2026 | CGEN COMPUGEN LTD | Exercise(M) | 2,000 | $1.15 | $2,300 | Direct |
| Apr 14, 2026 | CGEN COMPUGEN LTD | Sale(S) | 2,000 | $2.80 | $5,600 | Direct |
| Apr 10, 2026 | CGEN COMPUGEN LTD | Exercise(M) | 1,125 | $0.83 | $933 | Direct |
| Apr 10, 2026 | CGEN COMPUGEN LTD | Exercise(M) | 2,000 | $1.15 | $2,300 | Direct |
| Apr 10, 2026 | CGEN COMPUGEN LTD | Sale(S) | 3,125 | $2.56 | $8,013 | Direct |
| Apr 8, 2026 | CGEN COMPUGEN LTD | Exercise(M) | 4,375 | $0.83 | $3,628 | Direct |
| Apr 8, 2026 | CGEN COMPUGEN LTD | Exercise(M) | 1,000 | $1.15 | $1,150 | Direct |
| Apr 8, 2026 | CGEN COMPUGEN LTD | Sale(S) | 5,375 | $2.42 | $13,008 | Direct |
| Apr 7, 2026 | CGEN COMPUGEN LTD | Exercise(M) | 2,500 | $0.83 | $2,073 | Direct |
| Apr 7, 2026 | CGEN COMPUGEN LTD | Sale(S) | 2,500 | $2.30 | $5,750 | Direct |
| Apr 1, 2026 | CGEN COMPUGEN LTD | Exercise(M) | 2,500 | $0.83 | $2,073 | Direct |
| Apr 1, 2026 | CGEN COMPUGEN LTD | Exercise(M) | 1,000 | $1.15 | $1,150 | Direct |
| Apr 1, 2026 | CGEN COMPUGEN LTD | Sale(S) | 3,500 | $2.20 | $7,700 | Direct |
| Mar 26, 2026 | CGEN COMPUGEN LTD | Exercise(M) | 11,875 | $0.83 | $9,847 | Direct |
| Mar 26, 2026 | CGEN COMPUGEN LTD | Sale(S) | 11,875 | $2.04 | $24,187 | Direct |
1-20 of 20 transactions
About Levine Zurit
Levine Zurit (SEC CIK 0001972527) files insider reports with the SEC as SVP, Business Development of COMPUGEN LTD (CGEN).
Signal8 holds 10 ownership filings by Levine Zurit (1 Form 3, 9 Form 4), filed between Mar 18, 2026 and Jul 30, 2026. Those filings report 20 transactions, from Mar 26, 2026 to Jul 29, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Levine Zurit's filings is in HOLON.
Recent filings by Levine Zurit
- Jul 29, 2026: Grant or award of CGEN shares (Form 4, code A).
- Jul 9, 2026: Option exercise of CGEN shares (Form 4, code M).
- Jul 9, 2026: Open-market sale of CGEN shares (Form 4, code S).
- Apr 24, 2026: Open-market sale of CGEN shares (Form 4, code S).
- Apr 24, 2026: Option exercise of CGEN shares (Form 4, code M).
Other insiders filing for COMPUGEN LTD (CGEN)
- Silberman David, Chief Financial Officer
- Ophir Eran, President and CEO
- Cohen-Dayag Anat, Director
- Perry Eran, Director
- Ferre Pierre, Chief Operating Officer
- Kredo Russo Sharon, SVP, Research & Discovery